Cargando…
Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria
BACKGROUND: Cardiovascular disease reflects a major burden of non-communicable disease in Sub-Saharan Africa (SSA). Early detection and treatment of atrial fibrillation (AF), as a preventive measure against stroke, is currently not in the scope of the World Health Organization recommendation to redu...
Autores principales: | Jacobs, M. S., Adeoye, A. M., Owolabi, M. O., Tieleman, R. G., Postma, M. J., Van Hulst, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ubiquity Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641527/ https://www.ncbi.nlm.nih.gov/pubmed/34900571 http://dx.doi.org/10.5334/gh.893 |
Ejemplares similares
-
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017) -
Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019) -
Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options
por: Stambler, Bruce Sheldon, et al.
Publicado: (2015) -
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands
por: van Hulst, Marinus, et al.
Publicado: (2022) -
Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
por: Jacobs, Maartje S, et al.
Publicado: (2020)